Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban Concentration in Thai Patients with Nonvalvular Atrial Fibrillation: Real-World Study
TCTR20250905001Recruiting
- Sponsor
- Silpakorn University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of edoxaban in Atrial fibrillation (AFib), sponsored by Silpakorn University. Primary endpoint: Plasma edoxaban concentration. Started Jul 2025; status: recruiting.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20250905001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250905001.